Bio Protocol Enters V2 Phase, Users Can Earn BioXP Through Staking
Foresight News reports that Bio Protocol has entered the V2 phase and launched Launcher V2, allowing users to sell low-market-cap BioAgents, IP-Tokens, and BioDAOs. In addition, users can stake BIO and DeSci tokens to earn BioXP, and accumulate points by participating in activities. These points can be used to access new sales.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
USD/CHF Price Forecast: Shooting star warns bulls below 0.8200
Sysco Planning $1 Billion Share Offering
Matrix Service CFO Andrew J. Smith files initial beneficial ownership statement
Copasa MG declares R$ 0.26 dividend per share for 3Q 2026
